MLS Capital Fund II invests in a diversified portfolio of biogreentech companies at all stages of development.
MLS Capital Fund II invests in a diversified portfolio of biogreentech companies at all stages of development.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 3, 2022
Greenlight Biosciences
|
Post-IPO Equity | $125.50M | Agriculture | — |
Jun 16, 2020
Greenlight Biosciences
|
Series D | $102M | Agriculture | — |
MLS Capital Fund II has had 1 exits. MLS Capital Fund II most notable exits include Greenlight Biosciences
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 3, 2022 | Greenlight Biosciences | IPO | Agriculture | Detail |